CLSD vs QLGN
Comparison between Clearside Biomedical, Inc. Common Stock (CLSD, Company) and Qualigen Therapeutics, Inc. Common Stock (QLGN, Company).
Both CLSD and QLGN are from the Healthcare sector.
5-Year PerformanceCLSD has outperformed QLGN, delivering a return of -64.5% compared to -74.3%
CLSD vs QLGN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CLSD vs QLGN - Historical Returns
Returns include dividend reinvestment.
CLSD vs QLGN - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | CLSD | QLGN |
|---|---|---|
| 2026 | +0.00% | -50.42% |
| 2025 | -97.14% | -44.30% |
| 2024 | -26.36% | -84.80% |
| 2023 | -3.70% | -60.14% |
| 2022 | -61.11% | -89.08% |
| 2021 | -14.20% | -66.03% |
| 2020 | +29.86% | -41.84% |
| 2019 | +152.17% | -79.81% |
| 2018 | -85.12% | -80.77% |
| 2017 | -25.29% | -88.62% |
| 2016 | +23.31% | +66.26% |
| 2015 | N/A | -65.73% |
CLSD vs QLGN Drawdown Comparison
The maximum drawdown for CLSD was -99.89%, occurring on Nov 28, 2025. This drawdown has not yet recovered.
The maximum drawdown for QLGN was -100.00%, occurring on Feb 24, 2026. This drawdown has not yet recovered.
The current CLSD drawdown is -99.89%. The current QLGN drawdown is -100.00%.
| Rank | CLSD | QLGN |
|---|---|---|
| #1 | -99.89% Oct 11, 2016 - Nov 28, 2025 | -100.00% Jun 24, 2015 - Feb 24, 2026 |
| #2 | -17.17% Jun 2, 2016 - Aug 23, 2016 | N/A |
| #3 | -5.93% Sep 28, 2016 - Oct 3, 2016 | N/A |
| #4 | -5.91% Aug 23, 2016 - Aug 30, 2016 | N/A |
| #5 | -5.71% Sep 9, 2016 - Sep 19, 2016 | N/A |
| #6 | -4.10% Oct 3, 2016 - Oct 5, 2016 | N/A |
| #7 | -1.45% Sep 7, 2016 - Sep 9, 2016 | N/A |
| #8 | -1.09% Sep 21, 2016 - Sep 23, 2016 | N/A |
| #9 | -1.07% Aug 30, 2016 - Sep 1, 2016 | N/A |
| #10 | -0.67% Sep 2, 2016 - Sep 7, 2016 | N/A |
Correlation
Correlation between CLSD and QLGN is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks